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Autophagy represents a homeostatic cellularmechanism for the turnover of organelles and proteins, through a lysosome-dependent
degradation pathway. During starvation, autophagy facilitates cell survival through the recycling of metabolic precursors.
Additionally, autophagy can modulate other vital processes such as programmed cell death (e.g., apoptosis), inflammation, and
adaptive immune mechanisms and thereby influence disease pathogenesis. Selective pathways can target distinct cargoes (e.g.,
mitochondria and proteins) for autophagic degradation. At present, the causal relationship between autophagy and various forms
of regulated or nonregulated cell death remains unclear. Autophagy can occur in association with necrosis-like cell death triggered
by caspase inhibition. Autophagy and apoptosis have been shown to be coincident or antagonistic, depending on experimental
context, and share cross-talk between signal transduction elements. Autophagy may modulate the outcome of other regulated
forms of cell death such as necroptosis. Recent advances suggest that autophagy can dampen inflammatory responses, including
inflammasome-dependent caspase-1 activation andmaturation of proinflammatory cytokines. Autophagymay also act as regulator
of caspase-1 dependent cell death (pyroptosis). Strategies aimed at modulating autophagy may lead to therapeutic interventions for
diseases in which apoptosis or other forms of regulated cell death may play a cardinal role.
1. Introduction
Macroautophagy (abbreviated as “autophagy”) is a genet-
ically regulated and evolutionarily conserved pathway for
the degradation of subcellular components [1–5]. This pro-
cess involves the de novo formation of cytoplasmic double
membrane-bound vacuoles termed autophagosomes, which
sequester cytosolic cargo for delivery to the lysosomes [5,
6]. Autophagic cargoes may include various subcellular
targets typified by ubiquitin-modified or long-lived pro-
teins and major cytosolic organelles (e.g., mitochondria and
peroxisomes) [7–9]. However, a number of other potential
substrates have been identified, including lipids, nucleic
acids, reticulocytes, and invading pathogens (e.g., intracel-
lular bacteria, viruses, etc.) [7, 10]. The autophagic pathway
proceeds through several defined steps: (i) the initiation
phase involving the formation of an isolation membrane
or phagophore, (ii) the elongation of the phagophore, (iii)
the maturation of an autophagosome with assimilation of a
cytosolic cargo, (iv) the fusion of the mature autophagosome
to the lysosome, and finally (v) the degradation phase
where the contents are digested by lysosomal proteases (e.g.,
cathepsins) and other hydrolytic enzymes [1–5] (Figure 1).
Autophagy has been recognized as an essential function
for cell homeostasis and adaptation to environmental stress
conditions including nutritional starvation, energy depletion,
endoplasmic reticulum stress, oxidative stress, and hypoxia
[11–14]. Furthermore, autophagy plays a vital role in innate
and adaptive immune mechanisms, including resistance to
pathogen infections [10, 15, 16]. The role of autophagy in dis-
eases is an emerging area of investigation, with recent studies
indicating that autophagy may exert multifunctional roles in
specific diseases, with the potential for both adaptive and
maladaptive outcomes. Furthermore, deficiency or absence in
autophagic function may also contribute to the pathogenesis
of human diseases [2, 12, 17–19].
The occurrence of autophagy in response to environ-
mental stress, most notably starvation, is generally regarded
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Figure 1: Autophagy pathway. Autophagy is a membrane-dependent pathway that involves a defined series of steps. The pathway is initiated
by the autophagosome nucleation step (formation of a preautophagosomal structure leading to an isolation membrane or phagophore). This
is followed by autophagosome membrane elongation. The next steps involve the formation of the mature autophagosome, which engulphs
cytosol or specific substrates such asmitochondria or ubiquitinated proteins. Subsequently, the autophagosome containing its cargo fuses with
the lysosome. In the autolysosome, the autophagosomal cargoes are digested by lysosomal hydrolases and the contents released for metabolic
recycling.
as a cell survival mechanism [20–22]. Due to the often
coincident appearance of morphological and biochemical
markers of autophagy in cells that are dying, the relationship
between autophagy and cell death has been both exten-
sively studied and speculated upon [23–26]. Autophagy has
previously been classified as a form of programmed cell
death, termed “autophagic cell death” to describe a form
of caspase-independent necrosis-like cell death associated
with accumulation of autophagosomes in cells [27]. This
classification is now controversial, and the casual relationship
between autophagy and cell death remains unproven [25, 26].
Nevertheless, many studies have pointed to intimate rela-
tionships between autophagy and cellular death programs,
which are not yet fully understood [28]. Recent studies have
also examined potential cross-talk between the signaling
pathways that regulate autophagy and those that regulate
distinct forms of regulated cell death such as apoptosis [29].
Current advances in these areas will be summarized in this
review.
1.1. Modes of Cell Death. The major types of cell death
which have been studied most extensively in the context of
autophagy research include apoptosis, necrosis, necroptosis,
and pyroptosis, as briefly summarized here.
1.1.1. Apoptosis. Apoptosis denotes a regulated form of cell
death that requires the coordinated action of proteases and
nucleases within an intact plasma membrane. Morpholog-
ical characteristics of apoptosis include DNA fragmenta-
tion, plasma membrane blebbing, cell shrinkage, and cellu-
lar decomposition into membrane-bound apoptotic bodies
which are removed by phagocytosis [30–33]. The cardi-
nal biochemical features of apoptosis include mitochon-
drial dysfunction, respiratory chain inhibition, loss of inner
mitochondrial membrane potential (ΔΨ
𝑚
), increased mito-
chondrial membrane permeability, and externalization of
phosphatidylserine [30–33]. Apoptosis has a crucial function
in themaintenance of tissue homeostasis under physiological
conditions and also serves as a component of developmental
programs and furthermore may also contribute to disease
pathogenesis. Several intracellular signaling pathways may
activate apoptosis.The “intrinsic” (mitochondria-dependent)
apoptotic pathway represents a major mechanism by which
exposure to harmful extracellular stimuli triggers apoptosis.
This pathway is dependent on a proteolytic activation cascade
for both regulation and execution (i.e., caspases) and subject
to regulation by Bcl-2 family proteins. The extrinsic apop-
totic pathway, which shares common downstream features
with the intrinsic pathway, is defined by its dependence
on receptor-ligand (e.g., Fas-Fas ligand) interactions for
initiation.
1.1.2. Necrosis. Necrosis is a type of cell death that results
from acute, accidental, or nonphysiological injury [30–33].
This type of cell death is associated with cell lysis as the
consequence of membrane damage and subsequent leakage
of cell constituents into the extracellular space, which may
lead to local inflammation and damage to the surrounding
tissue. In certain cases, cell swelling or oncosis may precede
necrosis [33]. Necrosis and apoptosis differ in morpholog-
ical features, though the two processes are not necessarily
mutually exclusive. Both apoptosis and necrosis can occur in
response to treatment with many injurious stimuli, usually in
a dose-dependent fashion. Many agents that cause apoptosis
at low to moderate doses may ultimately cause necrosis at
relatively higher doses. A number of endogenous events can
determine the balance between apoptotic and necrotic death.
Cellular energy charge (i.e., ATP levels) may represent one
such factor that influences cell fate decisions.Whereas ATP is
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required for certain steps of caspase activation, rapid decline
of cellular ATP levels typically leads to necrotic cell death.
1.1.3. Necroptosis. The existence of necrotic cell death path-
ways regulated by an intrinsic death program distinct from
that of apoptosis has also been proposed. A regulated
Fas-dependent but caspase-independent nonapoptotic cell
death, termed “necroptosis,” that resembles necrosis has been
described [34, 35]. In this form of regulated necrosis, the
ligand binding of death receptors such as the tumor necro-
sis factor receptor 1 (TNFR1) can promote the formation
of a macromolecular complex (necrosome), involving the
receptor-interacting protein (RIP) kinase-1 and kinase-3 that
initiate necrosis [36, 37]. Increasing evidence affirms the
relevance of this mode of cell death in the pathogenesis of
various diseases [38–42].
1.1.4. Pyroptosis. Pyroptosis represents a form of cell death
that is triggered by proinflammatory signals and which is
associated with inflammation [32, 43, 44]. This type of
cell death occurs primarily in inflammatory cells such as
macrophages and may be triggered by bacterial or pathogen
infections. A major feature of pyroptosis is the requirement
for caspase-1 activation. Caspase-1 is responsible for the mat-
uration of proinflammatory cytokines such as IL-1𝛽 and IL-
18 through inflammasome-dependent pathways. Cells under-
going pyroptosis release increased amounts of IL-1𝛽 and IL-
18. The execution of pyroptosis may also require caspase-7.
Cells undergoing pyroptosis share some common features of
necrosis. Cell death occurs as a result of membranous pore
formation and cytoplasmic swelling and leakage of cytosolic
contents. Similar to apoptotic cells, pyroptotic cells may also
display DNA fragmentation and nuclear condensation.
1.2.Molecular Regulation of Autophagy. Theautophagic path-
way is highly regulated by a genetic program. The molecular
machinery of autophagic regulation is the subject of recent
reviews [45, 46]. Subsequent to their identification in yeast, a
number of critical autophagy-related genes (Atg) have been
identified whose gene products regulate distinct steps in the
induction or progression of autophagy [45, 46].
In brief, the autophagy pathway responds to regulation
by nutrient status, including nutrient deficiency (starvation)
and loss of energy charge [47]. Starvation induces autophagy
through the inhibition of mammalian target of rapamycin
(mTOR), which resides in a multiprotein complex, mTORC1
[47]. In response to stimulation by nutrients or growth
factors, mTORC1 negatively regulates a macromolecular
substrate complex that includes ULK1, ATG13, ATG101, and
FIP200 (RB1CC1), which results in autophagy suppression
[48–54]. Energy depletion, which stimulates autophagy,
inhibits mTORC1, in part through activation of the AMP-
dependent protein kinase (AMPK), leading to the activation
of ULK1, an important initiating step in autophagy [47, 55,
56].
Autophagy is also coregulated by a multiprotein com-
plex consisting of Beclin 1 (homologue of yeast Atg6),
which associates with class III phosphatidylinositol-3-kinase
(VPS34) and anumber of additional stimulatory or inhibitory
coregulatory proteins (e.g., ATG14L, UVRAG, Ambra1, and
Rubicon) [57]. In response to proautophagic stimuli, the
increased production of phosphatidylinositol-3-phosphate
(PI3P) by this complex regulates autophagosome formation
[57, 58].TheBeclin 1 complex is subject to negative regulation
by the PI3 K/Akt pathway [59] as well by binding interactions
with antiapoptotic Bcl-2 family proteins [60]. Following
phagophore formation, the elongation of the autophagosome
membrane requires the action of two ubiquitin-like conju-
gation systems: the Atg5-Atg12 conjugation system and the
microtubule-associated protein-1 light chain 3 (LC3, Atg8)
conjugation system [61, 62]. Atg4B converts the proform of
LC3B to its cytosolic free form (LC3-I). In mammals, the
conversion of LC3-I (and other Atg8 homologues) to its
phosphatidylethanolamine-conjugated and autophagosome-
membrane associated form (i.e., LC3-II) is an initiating step
in autophagy [63–66].
2. Autophagy in Cellular Homeostasis
Autophagy is now recognized to play multifunctional roles
in the maintenance of cellular homeostasis. Once thought to
be relatively nonspecific, it is now believed that autophagy
is a highly selective process in which distinct cellular
mechanisms are employed to identify and target cargo to
autophagosomes. Such selective autophagy pathways have
been identified for the turnover ofmitochondria (mitophagy)
and other organelles and the turnover of denatured protein
(aggrephagy).
2.1. Cell Survival during Starvation. During starvation (e.g.,
deprivation of glucose or growth factors or depletion of cel-
lular energy charge) autophagy prolongs cell survival through
the degradation and recycling of cellular macromolecules.
This process replenishes pools of precursor molecules dur-
ing nutrient deficiency states [20]. Mice deficient in the
autophagy protein Atg5 are susceptible to the lethal effects
of starvation [21]. Inhibition of autophagy by Beclin 1 or
Atg5 knockdown, or by chemical inhibitors such as 3-
methyladenine, can promote apoptosis and caspase-3 activa-
tion in starved HeLa cells [22]. These studies have suggested
a role for autophagy as a means for prolonging cell survival
during starvation.
2.2. Mitophagy. Autophagy performs a cardinal homeostatic
function in the removal of damaged or dysfunctional mito-
chondria, in a selective process referred to as mitophagy [9].
Mitophagy plays an important role in erythrocytematuration
and the maintenance of cellular homeostasis. The increased
turnover of mitochondria bymitophagymay occur as a result
of chemical or physical stress (e.g., hypoxia) [67]. Mitophagy
can regulate mitochondrial number to match metabolic
requirements. Mitochondria are removed during erythrocyte
maturation by the BH3-only protein, Nix/Bnip3L1. Nix local-
izes in the outer mitochondrial membrane and directly inter-
acts with mammalian Atg8 homologs through its LIR motif
[68]. Damaged or dysfunctional mitochondria are recruited
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to the autophagosome for removal by mitophagy through a
process regulated by the phosphatase and tensin homolog
deleted in chromosome 10 (PTEN)-induced putative kinase
1 (Pink1) and Parkinson protein-2 (Parkin) [9, 69, 70].
Mutations in the corresponding PINK1 and PARK2 genes are
associated with recessive familial forms of Parkinson’s disease
[71]. In mice, PINK1 and PARK2 deletions are associated with
mitochondrial dysfunction [72]. Loss ofmitochondrialmem-
brane potential and the increased production of mitochon-
drial reactive oxygen species (ROS) may provide initiating
signals formitophagy. Pink1, a transmembrane protein, is sta-
bilized on damaged or depolarized mitochondria. Following
the decline of mitochondrial membrane potential, which can
be caused by chemical stress, Pink1 recruits cytosolic Parkin,
an E3 ubiquitin protein ligase, to the mitochondria [69, 70,
73]. Parkin initiates the formation of polyubiquitin chains
which identify depolarized mitochondria for degradation.
Parkin ubiquitinatesmitochondrial outermembrane proteins
including porin, mitofusin, and Miro [74, 75]. Ubiquitinated
mitochondria are subsequently recognized and targeted to
autophagosomes by the autophagic cargo adaptor protein p62
[9, 69, 70].
2.3. Aggrephagy in the Maintenance of Proteostasis. Auto-
phagy can maintain cellular protein homeostasis (proteosta-
sis) by providing a mechanism for the removal of ubiq-
uitinated protein aggregates, in a selective process termed
aggrephagy [8]. Recent studies suggest that autophagy may
provide an alternative pathway to proteolysis in addition
to the ubiquitin proteasome system [76–78]. Aggrephagy
requires the selective autophagy cargo adaptor p62/SQSTM1
(p62) which can interact with ubiquitinated proteins through
a ubiquitin-associated (UBA) domain [76]. Furthermore,
p62 can interact with LC3 through its LIR (LC3-interacting
region) motif and thereby facilitate the targeting of ubiq-
uitinated proteins to autophagosomes [77]. The selective
autophagy adaptor, NBR1 (neighbor of BRCA1 gene 1), pro-
motes the formation of ubiquitin-positive protein aggregates,
facilitating their sequestration and removal by aggrephagy
[78]. This process involves the 400 kDa, PI3P-binding
autophagy-linked FYVE domain protein (ALFY), a p62-
interacting protein [79].
2.4. Other Forms of Selective Autophagy. In addition to
mitophagy, other forms of organelle-specific or substrate-
specific autophagy have been identified and collectively may
contribute to the maintenance of cellular integrity under
stress. These include the selective autophagic degradation of
peroxisomes [80], ribosomes [81], and endoplasmic retic-
ulum fragments [82]. In addition to protein, autophagic
processes have been implicated in the degradation of diverse
cellular biomolecules, including lipids [83] and RNA [84].
Furthermore, autophagy can degrade exogenously derived
substrates, most notably bacteria, virus particles, and other
parasites, in a selective process termed “xenophagy” [10, 15,
16]. Although recent studies begin to unravel the role of
mitochondrial selective autophagy in cell death pathways,
the role of diverse selective autophagy pathways in the
modulation of cell death programs remains largely uncharted
territory.
3. Autophagy and Apoptosis
Despite a widely accepted role for autophagy in cellular
survival, autophagy has also been associated with the regu-
lation of various cell death pathways, most notably apoptosis.
Autophagy is a regulated program associated with survival
or stress adaptation. However, increased autophagosome
formation is often coincident in cells that are dying. Thus,
autophagy may represent a failed adaptive mechanism that
may have prevented death under milder conditions. Hypo-
thetically, excess activation of autophagy may contribute to
apoptotic cell death through unchecked degradative pro-
cesses [23]. The morphological and biochemical features
of autophagy and apoptosis are distinct. Cells undergoing
autophagy display an increase in autophagic vesicles (i.e.,
autophagosomes and autophagolysosomes). While partial
chromatin condensation appears in autophagic cells, DNA
fragmentation does not occur. The distinctions between
autophagy and apoptosis remain incompletely delineated, as
the two processes are not always mutually exclusive and may
occur simultaneously in the same cell type.
3.1. Cross-Talk between Autophagy and Apoptosis Proteins.
Recent studies suggest that factors well known to regulate
apoptosis pathways also have the potential to exert regulatory
activity on factors that regulate autophagy and vice-versa
(Figure 2). How these regulatory events, termed “cross-talk”,
are integrated into a mechanism for the determination of cell
fate yet remains incompletely understood.
Antiapoptotic Bcl-2 family proteins, which downregu-
late apoptosis (i.e., Bcl-2) by antagonizing the activity of
proapoptotic proteins, can downregulate autophagy. Beclin 1
interacts with antiapoptotic Bcl-2 family members including
Bcl-2 and Bcl-X
𝐿
. Binding of these Bcl-2 family proteins to
Beclin 1 inhibits autophagy by preventing the association of
Beclin 1 with the class III PI3K complex [57, 60]. Recent
studies have identified Bcl-B as a novel Beclin 1 binding
protein [85]. BNIP3 is a BH3-only protein that can trigger
apoptosis by sequestering antiapoptotic Bcl-2 family proteins
and promoting Bax/Bad dependent mitochondrial release of
proapoptotic mediators. BNIP3 also stimulates mitophagy
by disrupting the interaction between Bcl-2 and Beclin 1
[86].These interactions suggest that autophagy and apoptosis
may be coordinately regulated by Bcl-2 family proteins.
Experimental evidence also suggests that, once activated,
apoptosis effector molecules may suppress autophagy; for
example, Beclin 1 may be cleaved and inactivated by caspases
during activation of apoptosis [87].
Further studies suggest that certain Atg proteinsmay play
dual roles in autophagy/apoptosis regulation; for example,
the autophagic protein Atg5 may affect extrinsic apopto-
sis pathways through interactions with the Fas-associated
death domain (FADD) protein [88]. Atg5 which regulates
autophagy can be subject to calpain-dependent cleavage to
generate a proapoptotic truncation product (tAtg5). This
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Figure 2: Autophagy is negatively regulated by the phosphatidylinositol 3-kinase (PI3 K)/Akt signaling pathway, which activates mammalian
target of rapamycin (mTOR) in response to growth factors and also phosphorylates Beclin 1. The adenosine 5󸀠-monophosphate-activated
protein kinase (AMPK) negatively regulates mTOR thereby acting as a positive regulator of autophagy in response to AMP levels.
mTOR resides in the mTOR signaling complex (mTORC1), which regulates the mammalian uncoordinated-51-like protein kinase (ULK1)
complex, consisting of ULK1, ATG13, ATG101, and RB1CC1. Autophagy is also regulated by the Beclin 1 complex, consisting of Beclin
1, class III phosphatidylinositol-3-kinase (VPS34 or PI3KC3) and ATG14L or UVRAG. Stimulation of the Beclin 1 complex generates
phosphatidylinositol-3-phosphate (PI3P), which triggers autophagosomal nucleation. Autophagosome membrane elongation is regulated
by ubiquitin-like conjugation systems. ATG12 is conjugated to ATG5 by ATG7 and ATG10 enzymes, which results in the formation of the
ATG5-ATG12-ATG16L1 complex.TheAtg8 conjugation system involvesmicrotubule-associated protein-1 light chain 3 (LC3, ATG8). LC3 and
other Atg8 homologues are modified with the cellular lipid phosphatidylethanolamine. Pro-LC3 is cleaved by ATG4B to generate the LC3-I
form. ATG4D may similarly process other Atg8 homologs. Lipid conjugation of LC3-I occurs from the action of ATG7 and ATG3 activities.
The conversion of LC3-I (free form) to LC3-II (lipid-conjugated form) is a major step in autophagosome formation. Antiapoptotic Bcl-2
family proteins can interact with the autophagy machinery at the site of Beclin1, resulting in inhibition of autophagy. The tumor suppressor
protein p53 and activated caspases potentially interact with the autophagy machinery at the indicated sites. Caspase processing can result in
activation of autophagy (e.g., Atg4D) or inhibition of autophagy (e.g., Beclin 1, Atg3). Additionally, Atg12 and a cleavage product of Atg5 can
act as proapoptotic mediators by antagonizing antiapoptotic Bcl-2 family proteins.
cleavage product promotes apoptosis by binding to and
inhibiting antiapoptotic proteins such as Bcl-X
𝐿
[89]. Recent
studies also implicate Atg12, the binding partner for Atg5
required for autophagosomal elongation, as an effector of
the intrinsic apoptosis pathway [90]. Atg12 may bind to and
inactivate antiapoptotic Bcl2 family proteins (e.g., Bcl-2 and
Mcl-1), through an interaction involving a BH2 motif, and
thereby act as a proapoptotic regulator [90].
Recent advances have identified other regulatory targets
for caspase regulation among autophagy related molecules;
for example, Atg4D, a member of the Atg4 family of Atg8
processing enzymes, has been identified as a substrate for
proapoptotic caspase-3 [91]. Caspase processing of Atg4D
results in activation with respect to proautophagic activity.
The autophagic protein Atg3 has recently been identified as a
caspase-8 substrate, which is cleaved during TNF𝛼-induced
apoptosis [92]. The antiapoptotic protein cellular Flice-like
inhibitory protein (c-FLIP) can act as a negative regulator
of autophagy [93]. The c-FLIP, an endogenous inhibitor of
caspase-8 processing and the extrinsic apoptotic pathway,
acts to prevent the binding of Atg3 to LC3, which impairs LC3
processing [93].
On the basis of what is known about the molecular cross-
talk between autophagy and apoptosis it currently remains
unclear whether autophagy and apoptosis are coregulated or
mutually exclusive processes. Antiapoptotic (e.g., Bcl-2) as
well as proapoptotic (e.g., caspase-3) molecules can down-
regulate autophagy by interactingwith Beclin 1. Furthermore,
other caspase-dependent events have been implicated in anti-
autophagy or proautophagy events. For example caspase
processing of Atg4D is proautophagy, whereas caspase pro-
cessing of Beclin 1 is antiautophagy.
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The definitive cellular mechanisms that control the deci-
sion to embark on each one or both of these pathways
in response to specific stimuli remain unclear. Analysis
of any single isolated regulatory component (using siRNA
knockdown for example) for its potential to cross-regulate
autophagy and/or apoptosis will be unlikely to answer
these questions. Thus, an integrative approach is needed to
understand how the entire molecular machinery of apop-
tosis and autophagy are coordinated to influence cell fate
decisions.
3.2. The Tumor Suppressor p53 Coregulates Autophagy and
Apoptosis. Thep53 tumor suppressor protein is a well studied
regulator of cell cycle progression and apoptosis. p53 modu-
lates the expression of Bcl-2 family proteins (e.g., Bax, Bid)
and other apoptosis-related gene targets (e.g., Apaf1). The
nuclear form of p53 targets the expression of DRAM (damage
regulated autophagic modulator), which can stimulate both
autophagy and apoptosis [94]. Alternatively, p53 can induce
autophagy through the upregulation of AMPK, which down-
regulates themTOR pathway [95]. Recent studies have shown
that genetic or pharmacological inhibition of p53 can also
activate autophagy and have led to the identification of the
cytoplasmic form of p53 as an inhibitor of autophagy [96].
Chemical stimuli known to induce autophagy can promote
the proteasomal degradation of p53 [96].
Cellular stimulation with interferon-𝛾 (IFN-𝛾) induces
the deacetylation of p53, leading to suppressed Bmf expres-
sion, reduced complex formation between Beclin 1 and Bcl2,
and enhanced autophagy [97]. Taken together these studies
suggest a complex role of p53 in the regulation of autophagy,
with opposing roles for the cytosolic and nuclear forms of p53
[98, 99].
3.3. Autophagy as a Protagonist of Apoptosis. Several recent
studies, supported by genetic manipulation of the autophagy
program, have revealed that in select toxicological models,
autophagy may be associated with the promotion of apopto-
sis.
In our recent studies we have found that epithelial
cells subjected to cigarette smoke extract (CSE) exposure
die by activation of the extrinsic apoptosis pathway [100,
101]. CSE-induced cell death involved activation of the
Fas-dependent death-inducing signaling complex (DISC)
and downstream activation of caspases (-8,-9,-3). Epithelial
cells subjected to CSE exposure concurrently responded
with increased autophagosome formation and increased
processing of LC3B-I to LC3B-II in epithelial cells [100,
101]. Knockdown of autophagy proteins Beclin 1 or LC3B
inhibited apoptosis in response to CSE exposure in vitro,
suggesting that increased autophagy occurred in association
with epithelial cell death [100, 101]. Further studies revealed
that LC3Bmay act as a regulatory factor in extrinsic apoptosis
in thismodel [101]. LC3Bwas found to engage a complex with
Fas, the key component of the DISC, in a fashion dependent
on the lipid raft protein caveolin-1. CSE exposure caused
the rapid dissociation of LC3B from Fas, in association with
the activation of apoptosis signaling [101]. In conclusion,
these results using genetic knockdown experiments have
implicated a proapoptotic role for LC3B, in a specialized
model of CSE-induced toxicity, though the relative role of
autophagic activity in promoting cell death in this model
remains unclear [100, 101].
It should be noted that CSE-induced autophagy may
differ from starvation-induced autophagy in that it occurs
in the presence of a complex mixture of foreign matter,
whichmay potentially alter the functionality of the autophagy
response.Thus, the concept of “toxic autophagy” may involve
altered function, which may be dependent not only on
whether its activation is physiological or excessive, but also
on the nature of foreign substrates (e.g., complex xenobiotics
such as tar or virus particles) and their interactions with
autophagosomes.
Further examples of coincident autophagy and apoptosis
include p53-dependent autophagy through upregulation of
DRAM, which is coincidental with upregulation of apoptosis
[93]. TNF𝛼 can induce autophagy in trophoblasts lead-
ing to activation of the intrinsic apoptosis pathway [102].
Knockdown of Atg5 prevented TNF𝛼-dependent activation
of proapoptotic caspases in this model [102]. Deletion of Atg5
was also shown to protect cells from prodeath environmental
stimuli; however, the authors attributed this resistance to
compensatory activation of chaperone-dependent autophagy,
rather than inhibition of macroautophagy per se [103].
These studies raise an important issue in that genetic
knockdown of one specific autophagy-related factor cannot
establish whether autophagy was protective or not in any
context, as downregulation of the targetmay potentially affect
signaling pathways that are independent of autophagy, or
alternatively, promote compensatory mechanisms, such as
alternate forms of autophagy.
4. Autophagy, Necrosis, and Necroptosis
4.1. Autophagy Dependent Cell Death during Apoptosis Inhi-
bition. The terms “autophagic cell death” or type II pro-
grammed cell death have been previously used to refer to cell
death distinct from apoptosis that occurs in association with
increases in autophagosome formation and independently of
caspases [26]. Many studies that have implicated autophagy
as a cell death effector have been performed on apoptosis-
compromised or caspase-deficient cells; for example, cells
treated with z-VAD-fmk, a general inhibitor of caspases, or
with caspase-8 and calpain inhibitors, die essentially by a
nonapoptotic pathway characterized by dramatic accumu-
lations of autophagic vacuoles [104–107]. Genetic knock-
down experiments (e.g., Beclin 1) suggest that autophagy
contributes to cytotoxicity in these models [104]; however,
contrasting studies, also using knockdown of autophagy
proteins, have also suggested that autophagy can also pro-
tect in the context of nonapoptotic cell death induced by
caspase inhibition [108]. In Bax−/−Bak−/− mouse embryonic
fibroblasts (MEFs), which cannot activate intrinsic apoptosis,
treatment with chemotherapeutic agents results in non-
apoptotic necrosis-like cell death accompanied by excessive
autophagosome formation [109].
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Currently it remains unclear whether the process of
autophagy acts as an effector or bystander of caspase-
independent necrosis-like cell death, though autophagic pro-
teins likely play an accessory role [25, 26].
4.2. Cross-Talk of Autophagy and Necrosis. Experiments in
tumor cells have suggested the possibility of cross-talk
between autophagy and necrosis in cells [110]. Autophagy
provides a protective function to limit tumor necrosis
and inflammation in response to metabolic stress. While
autophagy acts to buffer metabolic stress, the combined
impairment of apoptosis and autophagy promotes necrotic
cell death in vitro and in vivo [111]. Although it remains to
be determined what triggers necrosis in tumor cells, it is
likely that insufficient ATP production to maintain plasma-
membrane integrity results in metabolic catastrophe and cell
lysis [110, 112]. A rapid drop in ATP has been implicated
in necrosis [113]. Autophagy integrates a metabolic feedback
system to allow sufficient ATP generation to maintain cell
viability [114]. Enhanced autophagy by spermidine, a natural
polyamine, inhibits loss of membrane integrity and release
of chromatin protein high mobility group B1 (HMGB1), a
biomarker of necrosis [115].
Necrosis was once described as accidental cell death by
extreme physicochemical stress. However, recent consensus
agrees that specific genes can regulate necrosis, which is
termed necroptosis [35]. The kinases receptor-interacting
protein 1 (RIP1) and RIP3 are key signaling molecules in
necroptosis. Published studies have suggested that the treat-
ment with zVAD, a caspase inhibitor with broad specificity,
induced autophagy and the death of L929 cells; and this
death process required RIP1, suggesting that autophagy is
involved in necroptosis [107]. In several models, autophagy
has been shown to regulate necroptosis [116, 117]. In endothe-
lial cells, inhibition of autophagy rescues palmitic acid-
induced necroptosis [118]. On the other hand, a recent
study has demonstrated that necrostatin-1 (Nec-1), a specific
necroptosis inhibitor, suppressed not only necrosis but also
autophagy [119]. These observations suggest that autophagy
may be induced by necroptosis [120], raising the possibility
that cellular stress during cell deathmay lead to the induction
of autophagy. The molecular mechanism underlying this
relationship remains elusive and controversial [121]. It is
tempting to speculate that so-called autophagic cell death
may involve elements of necroptosis, though further research
will be needed to clarify this relationship, as well as the
signaling pathways linking autophagy to necroptosis.
5. Autophagy, Inflammasome Activation,
and Cross-Talk to Pyroptosis
Recent observations have revealed a relationship between
autophagic proteins and inflammasome-associated proin-
flammatory cytokine maturation in macrophages [122–124].
Inflammasomes are cytosolic multiprotein complexes that
constitute a novel inflammatory signaling mechanism and
which govern the maturation and secretion of distinct proin-
flammatory cytokines, such as IL-1𝛽, IL-18, and IL-33 [125].
Cytosolic receptors of the Nod-like receptor (NLR) family
(i.e., NLRP3, NLRP1) interact with accessory proteins to form
inflammasome complexes. NLRP3 interacts with an adaptor
protein [apoptosis-associated speck like protein containing
CARD (ASC)], which recruits and activates the procaspase-1
by proteolytic cleavage [125].
Proinflammatory cytokine secretion (IL-1𝛽 and IL-18)
was enhanced in atg16l1 or atg7 deleted macrophages in
response to LPS [122]. In contrast, atg16l1 or atg7 deficiency
did not affect TNF and IFN-𝛽 production or NF-𝜅B pathway
activation in macrophages stimulated with LPS [122]. Fur-
thermore, atg16l1 deleted mice displayed increased suscepti-
bility to amurinemodel of colitis, which could be ameliorated
by anti-IL-18 therapy [122]. Increased activation of IL-1𝛽 and
IL-18 has also been observed in macrophages and monocytes
isolated from mice genetically deficient in Beclin 1 and LC3B
[123]. Cytokine activation in response to LPS and ATP in
wild-type macrophages, as well as the amplification observed
in LC3B or Beclin 1 deficient macrophages, required the
NLRP3 inflammasome pathway [123, 124]. The mechanism
by which autophagy deficiency enhanced NLRP3 inflamma-
some pathway activation involved mitochondrial dysfunc-
tion, including the enhanced production of mitochondrial
ROS and increased mitochondrial membrane permeability
transition [122, 123]. The pathway to caspase-1 dependent
IL-18 secretion in macrophages was inhibited by mitochon-
drial targeting antioxidants [123]. These experiments suggest
that autophagic proteins dampen inflammasome pathway
activation by stabilizing mitochondria and/or maintaining
mitochondrial quality control through autophagy.
In contrast to negative regulation of autophagy by the
inflammasome, a recent study demonstrates that autophagy
induction by starvation enhances caspase-1 activation and
secretion of IL-1𝛽 and IL-18 [126]. Inflammasome-mediated
IL-1𝛽 secretion utilizes the autophagy-based unconventional
secretion pathway [126]. It is possible that a distinct type
of autophagy induction might differentially regulate the
inflammasome pathway.
Taken together these studies suggest an important role for
autophagic proteins in the dampening of proinflammatory
responses, which warrants further investigation in models of
inflammatory disease.
In addition to confirmed negative regulatory roles of
autophagy in inflammasome activation, it has been shown
that stimulation of inflammasome pathways can promote
autophagosome formation through activation of the GTPase
RalB [127]. Furthermore, p62-dependent selective autophagy
processesmay regulate the turnover and degradation of ubiq-
uitinated inflammasome complexes [127]. Further studies
suggest that stimulation of plasminogen activator inhibitor-2
by Toll like receptor activation suppresses NLRP3-dependent
cytokines activation by promoting the autophagic degra-
dation of NLRP3 [128]. An important and unanswered
question is related to whether inflammasome activation and
the generation of inflammasome-associated cytokines exert
downstream consequences on autophagic processing.
Pyroptosis is triggered in inflammatory cells in response
to excessive inflammation by caspase-1-dependent processes,
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Figure 3: Autophagy has a complex relationship with various modes of cell death, including regulated (e.g., apoptosis, pyroptosis, and
necroptosis) and catastrophic (e.g., necrosis) types of cell death. Autophagy has been implicated in association with caspase-independent
cell death in apoptosis-compromised cells leading to necrosis and necroptosis. Furthermore, autophagy has been implicated as an inhibitor
of both apoptosis and necrosis by preserving cellular functions, removing toxic debris, and maintaining cellular energy charge. Nevertheless,
proapoptotic roles of autophagy have also been reported. Proinflammatory stimuli can activate inflammasome-dependent caspase-1 activation
leading to proinflammatory cytokines maturation. Excess activation of this pathway can lead to pyroptotic cell death. Mitochondrial
dysfunction plays a key role in both apoptosis signaling and the activation of the inflammasome pathway. Autophagy can influence these
pathways throughmodulation of the mitochondrial pool.The relationships between autophagy and necroptosis or pyroptosis require further
elucidation.
leading to release of proinflammatory cytokines (e.g., IL-
1𝛽, IL-18, and IL-33) from dying cells. Recent studies sug-
gest that macrophages activate autophagy in parallel with
inflammasome activation, as a means to delay the onset of
pyroptosis [129]. Chemical inhibition of autophagy using 3-
methyladenine or inhibition of the Atg4 protease resulted
in increased incidence of pyroptotic cell death in activated
macrophages [129]. The impact of autophagy modulation
on the regulation of pyroptosis, and the relevance of these
interactions in in vivo models of inflammatory disease and
sepsis, warrants further exploration.
6. Conclusions and Therapeutic Implications
Autophagy is generally defined as a cellular program that
ensures survival under conditions of stress. The ability of
autophagy to clear damaged or denatured subcellular con-
stituents such as aggregated protein (i.e., aggrephagy) as well
as to maintain mitochondrial homeostasis (i.e., mitophagy)
appears to play important roles in the cytoprotective and
homeostatic functions of autophagy [20]. Despite the home-
ostatic roles, autophagy is now recognized to play complex
and incompletely understood roles in cell death programs
(Figure 3). Furthermore, there is considerable cross-talk
between the molecular regulation of autophagy and other
regulated forms of cell death [23–26]. The role of autophagy
in diseases is an emerging area of investigation, with recent
studies indicating that autophagy may exert multifunctional
roles in specific diseases, with the potential for both adaptive
and harmful outcomes. Furthermore, deficiency or absence
in autophagic function may play a pathogenic role in select
human diseases [2, 17–19]. Additional studies are needed to
define the dynamic equilibrium between autophagy, apopto-
sis, regulated necrosis, and other modes of cell death in the
context of human disease pathogenesis [121]. Furthermore,
additional studies are needed to determine the relevance of
autophagic regulation of pyroptosis in inflammatory diseases
[130]. An increased understanding of these relationships
would be essential in the development of therapeutics target-
ing the autophagy pathway for the treatment of disease.
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